Radiopharmaceutical Drugs Discovery and Evaluation
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (30 September 2019) | Viewed by 4657
Special Issue Editors
Interests: drug discovery; epigenetics; medicinal chemistry; chemical biology; radiopharmaceuticals
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
this Special Issue is related to recent advances in the field of research and development of radiopharmaceuticals.
Nuclear medicine plays a major role in the early detection, early therapy assessment and treatment follow-up of malignancies, cardiological and neurobiological disorders, infections, kidney and liver abnormalities. This is made possible by the application of radiopharmaceuticals for non-invasive imaging and/or treatment purposes. A tremendous amount of innovation is related to the use of a multiplicity of radionuclides, new or optimized multimodality imaging devices, and a plethora of recently marketed radiopharmaceuticals in all medical domains, particularly, in oncology, cardiology and neurology.
With this Special Issue we aim to highlight recent efforts in the radiopharmaceuticals’ development field with a special focus on innovative medicinal/pharmaceutical chemistry, chemical biology, pharmacological, and clinical approaches for identifying novel, highly potent, selective and safe radiopharmaceuticals. We expect new insights into the diagnostic and/or therapeutic potential of old and new radiopharmaceuticals, with special emphasis on their design and optimization, on the pharmacological evaluation, and the identification of new drug candidates, targets, and new potential applications in different medical settings.
Since the design, development and pharmacological validation of radiopharmaceuticals is a rather interdisciplinary process covering various disciplines of health and natural sciences, we are going to especially welcome original research articles, short communications as well as a limited number of review articles focused on innovative interdisciplinary approaches in the field of radiopharmaceutical drug development and evaluation. For planned papers, a title and a short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Dr. Dante Rotili
Prof. Alessandro Giordano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Nuclear medicine
- Radiochemistry
- Radiolabeling approaches
- Multimodality imaging probes
- Medicinal Chemistry
- Target validation
- Radiotracer metabolism
- Tumor imaging
- Tumor radio-guided surgery
- Radiopharmaceuticals
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.